TD Asset Management
ALXO icon

TD Asset Management’s ALX Oncology ALXO Stock Holding History

TD Asset Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-49,000
Closed -$546K – 1364
2024
Q1 		$546K Sell
49,000
-21,400
-30% -$301K ﹤0.01% 1284
2023
Q4 		$1.05M Buy
+70,400
New +$668K ﹤0.01% 1174
2020
Q4 		– Sell
-13,489
Closed -$509K – 1436
2020
Q3 		$509K Buy
+13,489
New +$530K ﹤0.01% 1236

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

TD Asset Management's ALXO Position: Q2 2024 in Review

TD Asset Management sold out of ALX Oncology (ALXO) in Q2 2024, closing a stake of 49,000 shares — an estimated $546K sold.

TD Asset Management first reported a position in ALXO in Q3 2020 and held it in 3 quarters. The position peaked at $1.05M in Q4 2023. 111 funds tracked by Wall St. Rank hold ALXO as of Q2 2024.

  • TD Asset Management reported no remaining ALX Oncology position as of Q2 2024 after selling out during the quarter.
  • TD Asset Management sold 49,000 ALX Oncology shares in Q2 2024, an estimated $546K.
  • TD Asset Management first reported a position in ALX Oncology in Q3 2020 and held it in 3 quarters.
  • TD Asset Management's ALX Oncology position peaked at $1.05M in Q4 2023.
  • 111 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2024.

Based on TD Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.